Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Latest filing published 21 Sept 2026 for Pharvaris N.V., €439k.
Filing timeline
BuySaleElisabeth Bjork
Insider track record
Disclosed buys
2
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-6.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Elisabeth Bjork: trading record in brief
This profile gathers the share dealings of Elisabeth Bjork across 2 companies, led by Pharvaris N.V. and Rocket Pharmaceuticals, Inc. Between 18 June 2025 and 17 September 2026, the trades on record add up to 8 filings.
Market trades split into 2 purchases (€59k) and 2 sales (€2.0M). On balance, insiders were net sellers of €1.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant and 3 option exercises. 2026 to date brings 1 purchase and 2 sales.
Most recently, on 21 September 2026, the filings show an option exercise worth €439k in Pharvaris N.V. The clock since the last published purchase (6 January 2026) now reads 291 days. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Elisabeth Bjork
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
35,000 shares@ US$14.39Common StockSEC:0001193125-26-396584:0
17,500 shares@ US$18.14Common StockSEC:0001193125-26-396584:1
52,500 shares@ US$37.8935Common StockSEC:0001193125-26-396584:2
10,000 shares@ US$8.050.0033% mcap21.5% of flowCommon StockSEC:0001193125-26-236432:0
10,000 shares@ US$29.31660.012% mcap78.5% of flowCommon StockSEC:0001193125-26-236432:1
10,000 shares@ US$3.4450.0% of flowCommon StockSEC:0001140361-26-000378:0
Canonical exit: 2 Apr 2026 (T+90)
10,000 shares@ US$3.41100.0% of flowCommon StockSEC:0001140361-25-033017:0
Canonical exit: 25 Nov 2025 (T+90)
30,000 shares0Common StockSEC:0001140361-25-026405:0
8 of 8 declarations
